Issue 6 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

6

June 24, 2005Jun 24, 2005

Free

DOWNLOAD THE PDF

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

Irinotecan And Carboplatin Improve Response In NSCLC

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

Gemcitabine Improves DFS In Resected Pancreatic Cancer

Rosenberg: Immunotherapy May Have Broad Potential

NCI-Approved Clinical Trials

Recent Issues

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025

Volume 51 | Issue 45 - December 12, 2025

Volume 51 | Issue 44 - December 05, 2025